Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies

T Robak, JA Burger, A Tedeschi, PM Barr, C Owen, O Bairey, P Hillmen, D Simpson, S Grosicki, S Devereux, H McCarthy, SE Coutre, H Quach, G Gaidano, Z Maslyak, DA Stevens, C Moreno, DS Gill, IW Flinn, JG GribbenA Mokatrin, M Cheng, L Styles, DF James, TJ Kipps, P Ghia

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Single-agent ibrutinib versus chemoimmunotherapy regimens for treatment-naïve patients with chronic lymphocytic leukemia: A cross-trial comparison of phase 3 studies'. Together they form a unique fingerprint.

Medicine & Life Sciences